Page last updated: 2024-12-08

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID161272
MeSH IDM0090882

Synonyms (15)

Synonym
deoxyadenylyl-3'5'-deoxythymidylate
adenosine, thymidylyl-(3'-5')-2'-deoxy-
d(tpa)
d(at)
dtl-dad
deoxyadenylyl-3'.5'-deoxythymidylic acid
d(a-t)
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine
(dapt)
19192-40-6
ta(asterisk)
[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl [(2r,3r,5s)-3-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl] hydrogen phosphate
9-[2-deoxy-5-o-(hydroxy{[3-(hydroxymethyl)-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1(2h)-yl)oxolan-2-yl]oxy}phosphoryl)pentofuranosyl]-9h-purin-6-amine
DTXSID20940833
2/'-deoxythymidylyl-(3/'-5/')-2/'-deoxyadenosine

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" To improve adherence to DAPT, the FDC (fixed dose combination) of Acetylsalicylic acid (ASA) and clopidogrel was developed into a single pill instead of two separate pills thus facilitating the dosage and administration of the therapy and increasing compliance."( Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life.
Costantini, A; Romagnoli, A; Santoleri, F, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.50)18.7374
1990's10 (31.25)18.2507
2000's3 (9.38)29.6817
2010's5 (15.63)24.3611
2020's10 (31.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.57 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (6.25%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (3.13%)0.25%
Other28 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]